Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, ...

Inhibition of CDK6 may prevent arteriovenous malformations in hereditary hemorrhagic telangiectasia by regulating endothelial ...

Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a ...

Those microglia expressing antiangiogenic factor TSP-1 made up a limited quantity of microglia in the OIR retina and thus failed to play protective roles in retinal angiogenesis. Apart from microglia, ...

After once losing almost all of his vision, the 30-year-old can now see images of his cornea, retina and optic nerve displayed in high-definition on a screen at the Sydney Eye Hospital.

Dubbed the Prima, the implant consists of a 2-mm square chip that is surgically placed under the retina, the backmost part of the eye, in an 80-minute procedure. A pair of glasses with a camera ...

Retinal degeneration (RD) is a leading cause of blindness worldwide ... The authors found that Metrnl stabilized endothelial function and inhibited angiogenesis in a mouse model of CNV. This molecule ...

[Image from Pixium Vision] Brain-computer interface (BCI) developer Science Corporation today announced preliminary clinical trial results for its Prima retina implant. The company owns the Prima ...

Stage 1 A line of demarcation between the normal retina nearer the optic nerve and the non-vascularized retina peripherally. Stage 2 A ridge of scar tissue that arises in the region of the ...